{"id":"https://openalex.org/W2000433012","doi":"https://doi.org/10.1097/00001813-199801000-00001","title":"Preclinical pharmacokinetics of paclitaxel and docetaxel","display_name":"Preclinical pharmacokinetics of paclitaxel and docetaxel","alternate_titles":[],"publication_year":1998,"publication_date":"1998-01-01","ids":{"openalex":"https://openalex.org/W2000433012","doi":"https://doi.org/10.1097/00001813-199801000-00001","mag":"2000433012","pmid":"https://pubmed.ncbi.nlm.nih.gov/9491787"},"language":"en","primary_location":{"id":"doi:10.1097/00001813-199801000-00001","doi":"https://doi.org/10.1097/00001813-199801000-00001","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-199801000-00001","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000433012"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065279964","display_name":"Alex Sparreboom","orcid":"https://orcid.org/0000-0003-2660-6644","observed_orcids":["https://orcid.org/0000-0003-2660-6644"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4405267285","display_name":"Daniel den Hoed Kliniek","ror":"https://ror.org/020rz5h24","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908","https://openalex.org/I4405267285"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alex Sparreboom","raw_affiliation_strings":["Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital Rotterdam, The Netherlands","Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital Rotterdam, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. Tel: (+31) 10 4391754","Fax: (+31) 10 4851618"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4405267285"]},{"raw_affiliation_string":"Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital Rotterdam, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. Tel: (+31) 10 4391754","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4405267285"]},{"raw_affiliation_string":"Fax: (+31) 10 4851618","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034151807","display_name":"Olaf van Tellingen","orcid":"https://orcid.org/0000-0002-1037-6269","observed_orcids":["https://orcid.org/0000-0002-1037-6269"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Olaf van Tellingen","raw_affiliation_strings":["Department of Clinical Chemistry, Antoni van Leeuwenhoek Huis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Chemistry, Antoni van Leeuwenhoek Huis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113557752","display_name":"Willem J. Nooijen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Willem J. Nooijen","raw_affiliation_strings":["Department of Clinical Chemistry, Antoni van Leeuwenhoek Huis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Chemistry, Antoni van Leeuwenhoek Huis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062227574","display_name":"Jos H. Beijnen","orcid":"https://orcid.org/0000-0003-0118-561X","observed_orcids":["https://orcid.org/0000-0003-0118-561X"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jos H. Beijnen","raw_affiliation_strings":["Department of Pharmaceutical Analysis and Toxicology, Faculty of Pharmacy, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands","Department of Pharmacy and Pharmacology, Slotervaart Hospital, Louwesweg 6,1066 EC, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Analysis and Toxicology, Faculty of Pharmacy, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Slotervaart Hospital, Louwesweg 6,1066 EC, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802065108"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.4413,"has_fulltext":false,"cited_by_count":156,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94894948,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"9","issue":"1","first_page":"1","last_page":"17"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9672999978065491,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9672999978065491,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.02239999920129776,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":1.0},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9760000109672546},{"id":"https://openalex.org/keywords/cremophor-el","display_name":"Cremophor EL","score":0.8849999904632568},{"id":"https://openalex.org/keywords/tween-80","display_name":"Tween 80","score":0.9570000171661377},{"id":"https://openalex.org/keywords/pharmaceutical-formulations","display_name":"drug formulation","score":0.5170000195503235},{"id":"https://openalex.org/keywords/nonlinearity","display_name":"nonlinearity","score":0.703000009059906},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.972000002861023},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.9900000095367432},{"id":"https://openalex.org/keywords/microtubule-inhibitors","display_name":"microtubule inhibitors","score":0.746999979019165},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.875},{"id":"https://openalex.org/keywords/species-dependence","display_name":"species dependence","score":0.7490000128746033},{"id":"https://openalex.org/keywords/hepatobiliary-excretion","display_name":"hepatobiliary excretion","score":0.9679999947547913},{"id":"https://openalex.org/keywords/hydroxylated-metabolites","display_name":"hydroxylated metabolites","score":0.7900000214576721},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.8920000195503235}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.9447402358055115},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.9055919647216797},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.828369677066803},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.593621015548706},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5791619420051575},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3506845533847809},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2655513286590576},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.23390868306159973}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005243","descriptor_name":"Feces","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00001813-199801000-00001","doi":"https://doi.org/10.1097/00001813-199801000-00001","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-199801000-00001","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmid:9491787","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9491787","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2126769133","https://openalex.org/W2102903528","https://openalex.org/W2056432867","https://openalex.org/W2136277895","https://openalex.org/W2504391849","https://openalex.org/W2006243213","https://openalex.org/W2092694477","https://openalex.org/W1567824943","https://openalex.org/W2323860656","https://openalex.org/W2365098957"],"abstract_inverted_index":{"The":[0,40,129],"taxanes":[1],"paclitaxel":[2,50,98,181,192],"and":[3,23,52,70,86,147,156,182,210,225],"docetaxel":[4,56,71,148,198],"represent":[5],"a":[6,31,73,94,226],"novel":[7],"class":[8],"of":[9,15,26,37,46,76,83,88,97,127,134,154,180,223,229],"antineoplastic":[10],"agents.":[11],"A":[12],"major":[13,110,221,227],"problem":[14],"both":[16,135,205,215],"drugs":[17],"is":[18,79,187,194,200,219,232],"their":[19,184],"low":[20,163],"aqueous":[21],"solubility":[22],"the":[24,35,109,114,125,168,173,177,220,230],"design":[25],"suitable":[27],"formulations":[28,41],"has":[29],"been":[30,63],"difficult":[32],"step":[33],"in":[34,99,113,124,142,167,176,204,211,234],"process":[36],"therapeutic":[38],"development.":[39],"currently":[42],"used":[43],"are":[44,66],"mixtures":[45],"Cremophor":[47,107],"EL:ethanol":[48],"for":[49,55],"(Taxol)":[51],"Tween":[53],"80:ethanol":[54],"(Taxotere),":[57],"but":[58,161],"many":[59],"new":[60],"approaches":[61],"have":[62,72],"tested":[64],"or":[65,239],"under":[67],"investigation.":[68],"Paclitaxel":[69,146],"similar":[74,201],"mechanism":[75],"action,":[77],"which":[78,101],"based":[80],"on":[81],"promotion":[82],"tubulin":[84],"assembly":[85],"inhibition":[87],"microtubule":[89],"disassembly.":[90],"Pharmacokinetic":[91],"studies":[92],"revealed":[93],"marked":[95],"non-linearity":[96],"mice,":[100],"appeared":[102],"to":[103,140],"result":[104],"exclusively":[105],"from":[106,138],"EL,":[108],"component":[111],"present":[112],"pharmaceutical":[115],"formulation.":[116],"An":[117],"almost":[118],"linear":[119],"pharmacokinetic":[120],"behavior":[121],"was":[122],"observed":[123],"case":[126],"docetaxel.":[128],"reported":[130],"plasma":[131],"protein":[132],"binding":[133],"compounds":[136],"ranged":[137],"76":[139],"97%":[141],"different":[143],"animal":[144],"species.":[145],"widely":[149],"distribute":[150],"into":[151],"most":[152],"tissues":[153],"mice":[155],"rats,":[157],"including":[158],"tumor":[159],"tissue,":[160],"only":[162],"concentrations":[164],"were":[165],"detected":[166],"central":[169],"nervous":[170],"system.":[171],"Despite":[172],"great":[174],"similarity":[175],"chemical":[178],"structures":[179],"docetaxel,":[183],"metabolic":[185],"profile":[186],"very":[188],"distinct.":[189],"Furthermore,":[190],"whereas":[191],"metabolism":[193,199],"largely":[195],"species":[196,203],"dependent,":[197],"across":[202],"isolated":[206],"hepatic":[207],"microsomal":[208],"fractions":[209],"vivo":[212],"models.":[213],"For":[214],"taxanes,":[216],"hepatobiliary":[217],"excretion":[218],"pathway":[222],"elimination":[224],"fraction":[228],"dose":[231],"excreted":[233],"feces":[235],"as":[236],"parent":[237],"drug":[238],"hydroxylated":[240],"metabolites.":[241]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000433012","counts_by_year":[{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
